20.21
0.88%
-0.15
Finanzdaten der Bicycle Therapeutics Plc Adr-Aktie (BCYC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
266.35%
19.53
|
5.331 | 5.352 | 11.40 | 4.896 |
Operating Expenses
|
13.97%
51.25
|
59.57 | 56.15 | 54.51 | 46.70 |
Interest Income/Expense |
0.12%
0.821
|
0.82 | 0.814 | 0.821 | 0.808 |
Benefits Costs and Expenses |
14.17%
46.44
|
54.11 | 52.98 | 54.52 | 44.58 |
Costs And Expenses |
4.88%
46.44
|
48.83 | 52.98 | 54.52 | 44.58 |
Operating Income/Loss |
41.52%
-31.72
|
-54.23 | -50.80 | -43.11 | -41.80 |
Nonoperating Income/Loss |
11.97%
4.803
|
5.456 | 3.171 | -0.009 | 2.121 |
Income/Loss From Continuing Operations Before Tax |
44.83%
-26.91
|
-48.78 | -47.63 | -43.12 | -39.68 |
Income Tax Expense/Benefit, Deferred |
171.99%
-0.767
|
-0.282 | 7.271 | -1.577 | -2.106 |
Income Tax Expense/Benefit |
209.37%
-0.35
|
0.32 | 2.272 | -0.517 | -0.618 |
Income/Loss From Continuing Operations After Tax |
45.90%
-26.56
|
-49.10 | -49.90 | -42.60 | -39.06 |
Net Income/Loss
|
45.90%
-26.56
|
-49.10 | -49.90 | -42.60 | -39.06 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1,750%
42.56
|
2.3007 | 39.58 | 30.19 | 30.00 |
Diluted Average Shares |
1,750%
42.56
|
2.3007 | 39.58 | 30.19 | 30.00 |
Basic Earnings Per Share |
45.13%
-0.62
|
-1.13 | -1.26 | -1.41 | -1.30 |
Diluted Earnings Per Share |
45.13%
-0.62
|
-1.13 | -1.26 | -1.41 | -1.30 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):